A clinical trial of 3D printed personalized Hydroxyapatite barrier membranes for vertical bone augmentation in the jaws

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200058049

Enrollment

Unknown

Registered

2022-03-27

Start date

2022-10-01

Completion date

Unknown

Last updated

2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maxillofacial bone, cartilage and soft tissue repair and reconstruction

Interventions

experimental group:Hydroxyapatite barrier membrane

control group:Guided bone regeneration

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Patients with vertical bone defects of the jaw requiring implant surgery; 2. Patients aged between 20 and 50; 3. Those who voluntarily participate in and sign the informed consent; 4. Patients who can tolerate surgery and autologous bone transplantation.

Exclusion criteria

Exclusion criteria: 1. High-risk patients with mental illness; 2. Those who were considered unsuitable for inclusion by the researchers.

Design outcomes

Primary

Measure	Time frame
Vertical bone increment height;	—

Countries

China

Contacts

Public ContactLai Qingguo

The Second Hospital of Shandong University

sdhospital@126.com+86 17660083277

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026